Key Takeaways
- • Wealthing VC Club operates as a curated co-investment platform for accredited investors and family offices, providing access to post-seed (Series A–D) opportunities alongside lead venture capital firms, founded in 2020 and based in Palo Alto.
- • The investment model combines VC fund precision with angel investor autonomy, designed as an alternative to traditional VC funds, angel groups, and special purpose vehicles (SPVs), with a focus on pooled structures that diversify risk while maintaining investor privacy.
- • Investment criteria require US-based companies with signed term sheets and lead VC commitment, spanning funding stages from seed-to-Series D in priced rounds or convertible note structures.
- • Portfolio focus includes ESG-aligned sectors (climate, healthcare) and high-impact verticals, with demonstrated traction in healthcare diagnostics—including portfolio company Avenda Health's AI-driven prostate cancer diagnostic platform launched within one year of Wealthing investment.
- • Founder Alicia Castillo leads the organization, which provides curated deal flow, pre-investment analysis, and post-investment support through an advisor network and vetted third-party service providers.
Summary
Wealthing VC Club is an exclusive investment collective designed for accredited investors and family offices seeking exposure to early-stage growth companies. Founded in 2020, the platform operates from Palo Alto and was established as a structural alternative to conventional VC funds and angel syndicates, positioning itself at the intersection of institutional rigor and individual investor autonomy.
The investment thesis targets post-seed financing rounds (Series A through Series D) in US-based companies that have secured lead venture capital commitments and executed binding term sheets. This requirement for a lead VC serves as a credential filter, reducing selection risk and aligning the club's capital with established institutional backing. The platform accepts both priced equity rounds and convertible note instruments, offering portfolio construction flexibility across growth stages.
The organization's investment strategy emphasizes impact-driven sectors, particularly those aligned with Environmental, Social, and Governance (ESG) frameworks. Portfolio exposure spans climate-focused companies, healthcare innovation, and sector-specific applications. A notable portfolio company, Avenda Health, exemplifies this thesis: the cancer diagnostics firm raised capital through Wealthing and subsequently launched a multi-modal spatial artificial intelligence platform for prostate cancer care within a year—addressing an addressable market exceeding $100 billion. CEO Alicia Castillo leads the organization and provides both capital and operational guidance to portfolio founders.
The structural design of Wealthing VC Club prioritizes risk mitigation and confidentiality through pooled investment mechanisms, while maintaining individual investor discretion in deal selection. The platform provides curated deal sourcing, pre-investment due diligence, and post-investment value-add services through a vetted advisor and service provider network. This model allows accredited investors to achieve institutional-grade deal access and portfolio construction without the capital commitments or fee structures associated with traditional venture partnerships.
The investment thesis targets post-seed financing rounds (Series A through Series D) in US-based companies that have secured lead venture capital commitments and executed binding term sheets. This requirement for a lead VC serves as a credential filter, reducing selection risk and aligning the club's capital with established institutional backing. The platform accepts both priced equity rounds and convertible note instruments, offering portfolio construction flexibility across growth stages.
The organization's investment strategy emphasizes impact-driven sectors, particularly those aligned with Environmental, Social, and Governance (ESG) frameworks. Portfolio exposure spans climate-focused companies, healthcare innovation, and sector-specific applications. A notable portfolio company, Avenda Health, exemplifies this thesis: the cancer diagnostics firm raised capital through Wealthing and subsequently launched a multi-modal spatial artificial intelligence platform for prostate cancer care within a year—addressing an addressable market exceeding $100 billion. CEO Alicia Castillo leads the organization and provides both capital and operational guidance to portfolio founders.
The structural design of Wealthing VC Club prioritizes risk mitigation and confidentiality through pooled investment mechanisms, while maintaining individual investor discretion in deal selection. The platform provides curated deal sourcing, pre-investment due diligence, and post-investment value-add services through a vetted advisor and service provider network. This model allows accredited investors to achieve institutional-grade deal access and portfolio construction without the capital commitments or fee structures associated with traditional venture partnerships.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.